Gene · 326
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unsupervised Flow Cytometry Reveals a Constant Shift Towards Activated CD4+ T Cell Subsets in APECED. | Scand J Immunol | 2026 | 42359980 | PubTator, text mining | PubMed |
| Thymic APC Networks Orchestrate T-Cell Selection: Mechanisms and Therapeutic Opportunities in Immune Disorders. | Immunology | 2026 | 42339513 | PubTator, text mining | PubMed |
| Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1. | JCEM Case Rep | 2026 | 42273283 | PubTator, text mining | PubMed |
| Limited penetrance of dominantly inherited AIRE variants in a population-based cohort. | Hum Mol Genet | 2026 | 42262224 | PubTator, text mining | PubMed |
| SUMO3/RUNX1/AIRE/RCAN1 and DNMT3L/DYRK1A/Let-7c-5p/VEGF axes: immune dysregulation and genetic susceptibility as pulmonary risk factors in Down syndrome. | 3 Biotech | 2026 | 42245386 | PubTator, text mining | PubMed |
| The novel integrin-linked kinase inhibitor nilotinib suppresses cancer progression by promoting ubiquitylation of autoimmune regulator in oesophageal squamous cell carcinoma. | Anticancer Drugs | 2026 | 42069146 | PubTator, text mining | PubMed |
| Autoimmune polyglandular syndrome type 1 with compound heterozygous AIRE gene pathogenic variants and stage 1 type 1 diabetes mellitus: case report and literature review of Chinese population. | Front Immunol | 2026 | 41993177 | PubTator, text mining | PubMed |
| Immune dysregulation in thymoma: a potential mechanistic link to secondary lung cancer-a case report. | Mediastinum | 2026 | 41982617 | PubTator, text mining | PubMed |
| Retinopathy caused by a primary immune regulatory disorder - the spectrum of AIRE-associated retinopathy: case series and literature review. | Eye (Lond) | 2026 | 41957123 | PubTator, text mining | PubMed |
| Multimerizing transcription factors FOXP3 and AIRE as chromatin architectural regulators. | Nat Immunol | 2026 | 41933202 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitor-related myocarditis in patients with thymic epithelial tumors: a retrospective cohort analysis. | Cancer Immunol Immunother | 2026 | 41925910 | PubTator, text mining | PubMed |
| Direct contact with natural killer cells reprograms monocyte-derived dendritic cells into a tolerogenic phenotype. | Immunohorizons | 2026 | 41886078 | PubTator, text mining | PubMed |
| Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis. | J Immunol | 2026 | 41847848 | PubTator, text mining | PubMed |
| Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy. | Cancer Immunol Immunother | 2026 | 41843177 | PubTator, text mining | PubMed |
| Late-onset combined immunodeficiency and bone marrow failure in severe autoimmune hepatitis: a case report. | J Med Case Rep | 2026 | 41834055 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitors in Malignant Melanoma: Anti-PD-1, Anti-CTLA-4 and Anti-LAG-3 Therapies. | Curr Oncol Rep | 2026 | 41790359 | PubTator, text mining | PubMed |
| Oncostatin M receptor deficiency as a novel candidate genetic cause of autosomal recessive hyper-IgE syndrome. | J Hum Immun | 2026 | 41783139 | PubTator, text mining | PubMed |
| Ocular manifestations of STAT3 gain-of-function syndrome: A case of papillitis, retinitis, and retinal vasculitis. | Am J Ophthalmol Case Rep | 2026 | 41778090 | PubTator, text mining | PubMed |
| Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosis. | Tumori | 2026 | 41766228 | PubTator, text mining | PubMed |
| A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes. | Immun Inflamm Dis | 2026 | 41757399 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/326/papers?page=2